期刊文献+

OCT4异构体在人胚胎干细胞和间充质干细胞中的表达 被引量:3

Expression of OCT4 isoforms in human embryonic and mesenchymal stem cells
暂未订购
导出
摘要 目的比较OCT4异构体(OCT4A、OCT4B、OCT4B1)及其调控因子在人胚胎干细胞(hESC)和人间充质干细胞(hMSC)中的表达。方法利用RT-PCR、免疫荧光染色、流式细胞分析及体内/外分化实验,鉴定hESC及hMSC的生物学特性;应用real-time PCR、Western blot和流式细胞分析比较OCT4异构体及其转录因子NANOG,SOX2和mRNA结合蛋白LIN28在hESC及hMSC中的表达水平。结果 OCT4异构体mRNA在hESC和hMSC中均有表达,在hESC中的表达显著高于在hMSC中,并以OCT4A的差别最为显著(P<0.01);在蛋白水平,hESC表达OCT4A和OCT4B-256aa,hMSC不表达OCT4异构体蛋白。hESC高表达OCT4的调控因子NANOG、SOX2和LIN28;hMSC低表达SOX2,不表达NANOG和LIN28。结论 NANOG、SOX2和LIN28调控OCT4的表达,OCT4异构体在hESC和hMSC中的表达差异提示其可能是不同发育阶段干细胞自我更新和分化潜能等方面差别的主要因素之一。 Objective To compare the expression of OCT4 isoforms in human embryonic stem cells( hESCs) and in human mesenchymal stem cells( hMSCs). Methods The characterization of hESCs and hMSCs were performed by RT-PCR,immunofluorescence staining,flow cytometry and in vivo / vitro differentiation assays. The expressions of OCT4 isoforms and regulators that control their transcription(NANOG,SOX2)and translation(LIN28)were quantified by real-time PCR,flow cytometry and Western blot. Results Three OCT4 isoforms of mRNA were ex-pressed in both hESC and hMSC. However,their expression was significantly higher in hESC than that in hMSC, especially for OCT4A(P 〈0. 01). At protein level,OCT4A and OCT4B-265aa were translated in hESC while no OCT4 protein was be detected in hMSC. NANOG,SOX2 and LIN28 were highly translated in hESCs while hMSCs were weak positive for SOX2 expression and negative for NANOG and LIN28. Conclusions NANOG,SOX2 and LIN28 regulate the expression of OCT4. The different expression profile of OCT4 isoforms in hESC and hMSC indi-cates that OCT4 may be one of the important factors resulting in the differences of self-renewal and differentiation potentials of stem cells at different developmental stages.
出处 《基础医学与临床》 CSCD 北大核心 2014年第1期41-46,共6页 Basic and Clinical Medicine
基金 国家自然科学基金(31201102 30871433 31071305)
关键词 人胚胎干细胞 间充质干细胞 OCT4 选择性剪切 human embryonic stem cells human mesenchymal stem cells OCT4 alternative splicing
  • 相关文献

参考文献2

二级参考文献23

  • 1Atlasi, Y., Mowla, S.J., Ziaee, S.A., Gokhale, P.J., and Andrews, P.W. (2008). OCT4 spliced variants are differentially expressed in human pluripotent and nonpluripotent cells. Stem Cells 26: 3068-3074.
  • 2Cauffman, G., Van de Velde, H., Liebaers, I., and Van Steirteghem, A. (2005). Oct-4 mRNA and protein expression during human preimplantation development. Mol. Hum. Reprod. 11: 173-181.
  • 3Cauffman, G., Liebaers, I., Van Steirteghem, A., and Van de Velde, H. (2006). POU5F1 isoforms show different expression patterns in human embryonic stem cells and preimplantation embryos. Stem Cells 24: 2685-2691.
  • 4Ho, S.N., Hunt, H.D., Horton, R.M., Pullen, J.K., and Pease, L.R. (1989). Site-directed mutagenesis by overlap extension using the polymerase chain reaction. Gene 77: 51-59.
  • 5Irimia, M., Penny, D., and Roy, S.W. (2007). Coevolution of genornic intron number and splice sites. Trends Genet. 23: 321-325.
  • 6Keller, E.B., and Noon, W.A. (1984). Intron splicing: a conserved internal signal in introns of animal pre-mRNAs. Proc. Natl. Acad. Sci. USA 81: 7417-7420.
  • 7Keller, E.B., and Noon, W.A. (1985). Intron splicing: a conserved internal signal in introns of Drosophila pre-mRNAs. Nucleic Acids Res.13: 4971-4981.
  • 8Kotoula, V., Papamichos, S.I., and Lambropoulos, A.F. (2008). Revisiting OCT4 expression in peripheral blood mononuclear cells. Stem Cells 26:290-291.
  • 9Papamichos, S.I., Kotoula, V., Tarlatzis, B.C., Agorastos, T., Papazisis, K., and Lambropoulos, A.F. (2009). OCT4B1 isoform: the novel OCT4 alternative spliced variant as a putative marker of sternness. Mol. Hum. Rcprod. 15: 269-270.
  • 10Scholer, H.R., Ruppert, S., Suzuki, N., Chowdhury, K., and Gruss, P. (1990). New type of POU domain in germ line-specific protein Oct-4. Nature 344: 435-439.

共引文献9

同被引文献23

  • 1Thomson JA, hskovitz-Ehlor J, Shapiro SS, et al. Emblymic stem cell lines derived from human blastncysls [ J ]. Science, 1998, 282: 1145-1147.
  • 2Stummantl TC, Bremer S. The possible impac! of human enrbl.yonic stern cells on safely pharmacological and toxicological assessments in drug discovery anti drug development [ J ]. Curr Stem (Sell Res Ther, 2008, 3: 118-131.
  • 3Environment Directorate, joint Meeting Of The Chemicals Committee, The Working Party On Chemicals, Peslitides And Bioteehnolo. Oecd Series On Testing And Assessment Number 34, Guidance Document On The Validation And Intenmtional Acceptance Of New Or Updated Test Methods For Hazard Assessment [ EB/OL]. (2005438-18) [ 2014436-16 ]. hup:// nip. niehs, nih. gov/iccvam/suptMos/ddocs/oecd/oecd-gd34. pdf.
  • 4中华人民共和国国家质最监督检验检疫总局.GB/T 16886.5-2003/ISO-10993-5:1999医疗器械的生物学评价第5部分:体外细胞毒悱试验[S].北京:中华人民共和国国家质量监督检验检疫总局,2003.
  • 5Wang X, Li S, Cao T, el al. Evaluating biottxieity with fil,nblasts erived tom Imman embryonic stem cells [ J ]. Toxicol In Vitro, 2012, 26: 1056-1063.
  • 6Cao T, l,u K, Fu X, et al. Differentiated fibroblastic progenies of hmnan embD, onie stem fells for toxicology screening[ J ]. Cloning Stem Cells, 2008, 10:1-10.
  • 7WiCell Research Institute. WiCell Feeder Based (MEF) Pluripotent Stem Cell Protocols [ EB/OL ]. ( 2013-08-08 ) [ 2014- 06-16]. http://www, wicell, org/media, aeux/91bedb60-0ba8- 4 b48-be71 - 13fle71 b7 aea.
  • 8Fu X, Jh WS, Liu tt, el al. Establishment of clinally compliant human embrymi stem ceils in an autogous eeder-free system[J].Tissue Eng Part C Methods, 2011. 17: 927-937.
  • 9Fa X, Toh WS, Liu FI, et al. Autolngous feder cells from embryoid body outgrowth support the long-term growth of human emlryonic stem ceils more effectively than those from direct differentiation[J]. Tissue Eng Pari C Metlmds, 2010, 16: 719- 733.
  • 10International Stem Cell Banking Initiative. Consensus guidanee tbr banking and supply of hunlan embrymie stem cell lines lbr research pnrposes [ J ]. Stem Cell Rev, 2009, 5 : 301-314.

引证文献3

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部